Detalles de la búsqueda
1.
Pediatric ERCP: Factors for Success and Complication-A 17-Year, Multisite Experience.
J Pediatr Gastroenterol Nutr
; 77(3): 413-421, 2023 09 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37399144
2.
Safety and efficacy of dyslipidemia treatment in NAFLD patients: a meta-analysis of randomized controlled trials.
Ann Hepatol
; 27(6): 100738, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35781090
3.
Symptoms Suggestive of Gastroparesis in a Community-Based Cohort of European Americans and African Americans with Type 2 Diabetes Mellitus.
Dig Dis Sci
; 65(8): 2321-2330, 2020 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-31820181
4.
Predictors of Net Acid Excretion in the Chronic Renal Insufficiency Cohort (CRIC) Study.
Am J Kidney Dis
; 74(2): 203-212, 2019 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-30910373
5.
The Evolving Role of Rituximab in Adult Minimal Change Glomerulopathy.
Am J Nephrol
; 45(4): 365-372, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-28315862
6.
Recurrent Instability After Arthroscopic Bankart Reconstruction: A Systematic Review of Surgical Technical Factors.
Arthroscopy
; 33(11): 2081-2092, 2017 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-28866342
7.
Thrombosis Rates and Genetic Thrombophilia Risk Among Patients With Advanced Germ Cell Tumors Treated With Chemotherapy.
Clin Genitourin Cancer
; 22(3): 102086, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38697880
8.
RNA-Based Homologous Recombination Deficiency Signature Detects Homologous Recombination Deficiency-RNA+ Patients With and Without Homologous Recombination Repair Gene Pathogenic Alterations in Men With Prostate Cancer.
JCO Precis Oncol
; 7: e2300378, 2023 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-38061006
9.
Prognostic value of galectin-1 and galectin-3 expression in localized urothelial bladder cancer.
Transl Androl Urol
; 12(2): 228-240, 2023 Feb 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-36915891
10.
Pancreatic Stones and Extracorporeal Shockwave Lithotripsy: A Review of the Literature.
Pancreas
; 51(8): 916-922, 2022 09 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36607935
11.
A phase 2 trial of avelumab in men with aggressive-variant or neuroendocrine prostate cancer.
Prostate Cancer Prostatic Dis
; 25(4): 762-769, 2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-35292724
12.
Evaluation of tumor microenvironment and biomarkers of immune checkpoint inhibitor response in metastatic renal cell carcinoma.
J Immunother Cancer
; 10(10)2022 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-36252996
13.
The Association between a Decrease in On-Treatment Neutrophil-to-Eosinophil Ratio (NER) at Week 6 after Ipilimumab Plus Nivolumab Initiation and Improved Clinical Outcomes in Metastatic Renal Cell Carcinoma.
Cancers (Basel)
; 14(15)2022 Aug 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-35954493
14.
PROMISE: a real-world clinical-genomic database to address knowledge gaps in prostate cancer.
Prostate Cancer Prostatic Dis
; 25(3): 388-396, 2022 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-34363009
15.
A Case of Prolapsed Gastropathy Syndrome Presenting as Hematemesis and Acute Blood Loss Anemia.
Cureus
; 13(1): e12563, 2021 Jan 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-33564552
16.
A Multi-institutional, Retrospective Analysis of Patients with Metastatic Renal Cell Carcinoma to Bone Treated with Combination Ipilimumab and Nivolumab.
Target Oncol
; 16(5): 633-642, 2021 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-34379283
17.
Clinical outcomes in patients with metastatic renal cell carcinoma and brain metastasis treated with ipilimumab and nivolumab.
J Immunother Cancer
; 9(9)2021 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-34518292
18.
LRP1B mutations are associated with favorable outcomes to immune checkpoint inhibitors across multiple cancer types.
J Immunother Cancer
; 9(3)2021 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-33653800
19.
Association of baseline neutrophil-to-eosinophil ratio with response to nivolumab plus ipilimumab in patients with metastatic renal cell carcinoma.
Biomark Res
; 9(1): 80, 2021 Nov 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-34732251
20.
Combination antiangiogenic tyrosine kinase inhibition and anti-PD1 immunotherapy in metastatic renal cell carcinoma: A retrospective analysis of safety, tolerance, and clinical outcomes.
Cancer Med
; 10(7): 2341-2349, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33650321